These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 29358918)
1. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease. Yang X; Qian Y; Xu S; Song Y; Xiao Q Front Aging Neurosci; 2017; 9():441. PubMed ID: 29358918 [TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease. Fang X; Liu S; Muhammad B; Zheng M; Ge X; Xu Y; Kan S; Zhang Y; Yu Y; Zheng K; Geng D; Liu CF Neural Regen Res; 2024 Sep; 19(9):2081-2088. PubMed ID: 38227539 [TBL] [Abstract][Full Text] [Related]
4. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease. Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705 [TBL] [Abstract][Full Text] [Related]
5. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF- Zhao Z; Li F; Ning J; Peng R; Shang J; Liu H; Shang M; Bao XQ; Zhang D Acta Pharm Sin B; 2021 Sep; 11(9):2859-2879. PubMed ID: 34589401 [TBL] [Abstract][Full Text] [Related]
6. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease. Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422 [TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota. Zhang Y; Xu S; Qian Y; Mo C; Ai P; Yang X; Xiao Q Front Aging Neurosci; 2023; 15():1099018. PubMed ID: 36761177 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030 [TBL] [Abstract][Full Text] [Related]
9. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease. Bhattarai Y; Si J; Pu M; Ross OA; McLean PJ; Till L; Moor W; Grover M; Kandimalla KK; Margolis KG; Farrugia G; Kashyap PC Gut Microbes; 2021 Jan; 13(1):1866974. PubMed ID: 33459114 [TBL] [Abstract][Full Text] [Related]
11. Environment-contact administration of rotenone: A new rodent model of Parkinson's disease. Liu Y; Sun JD; Song LK; Li J; Chu SF; Yuan YH; Chen NH Behav Brain Res; 2015 Nov; 294():149-61. PubMed ID: 26239001 [TBL] [Abstract][Full Text] [Related]
12. Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats. Hu XM; Song LZ; Zhang ZZ; Ruan X; Li HC; Yu Z; Huang L Front Microbiol; 2024; 15():1358525. PubMed ID: 38450172 [TBL] [Abstract][Full Text] [Related]
13. Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson's disease: An animal study. Yan Z; Yang F; Sun L; Yu J; Sun L; Si Y; Yao L Brain Behav Immun; 2022 Nov; 106():307-321. PubMed ID: 36126853 [TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598 [TBL] [Abstract][Full Text] [Related]
15. Gut bacterial composition in a mouse model of Parkinson's disease. Perez-Pardo P; Dodiya HB; Engen PA; Naqib A; Forsyth CB; Green SJ; Garssen J; Keshavarzian A; Kraneveld AD Benef Microbes; 2018 Sep; 9(5):799-814. PubMed ID: 30099890 [TBL] [Abstract][Full Text] [Related]
16. [Effects of Nardostachys jatamansi on gut microbiota of rats with Parkinson's disease]. Wan GH; Wei XJ; Li JY; Yang X; Yu JH; Liu JF; Wang YQ; Lyu Y; Jin ZX; Shi JL Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):499-510. PubMed ID: 35178995 [TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice. Yang H; Shao Y; Hu Y; Qian J; Wang P; Tian L; Ni Y; Li S; Al-Nusaif M; Liu C; Le W CNS Neurosci Ther; 2024 Aug; 30(8):e70003. PubMed ID: 39161161 [TBL] [Abstract][Full Text] [Related]
18. Study of the gut microbiome in Egyptian patients with Parkinson's Disease. Mehanna M; AbuRaya S; Ahmed SM; Ashmawy G; Ibrahim A; AbdelKhaliq E BMC Microbiol; 2023 Jul; 23(1):196. PubMed ID: 37481569 [TBL] [Abstract][Full Text] [Related]
19. Brain-gut-microbiota axis in Parkinson's disease. Mulak A; Bonaz B World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021 [TBL] [Abstract][Full Text] [Related]
20. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease. Liang F; Chen CY; Li YP; Ke YC; Ho EP; Jeng CF; Lin CH; Chen SK J Parkinsons Dis; 2022; 12(8):2423-2440. PubMed ID: 36155528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]